PsyBio Therapeutics Corp. Begins Trading on the TSX Venture Exchange Feb 26 • 3 min read PsyBio Therapeutics Corp. announced that the company will commence trading on the TSX Venture Exchange under the ticker symbol “PSYB”.
PharmaDrug Files For FDA Orphan Drug Designation For DMT Feb 25 • 5 min read PharmaDrug Inc. announced it has expanded its psychedelic pharmaceutical program with the filing of an application with the U.S. Food and Drug Administration.
NeonMind Purchases Synthetic Psilocybin from Psygen Labs Feb 24 • 6 min read NeonMind Biosciences Inc. announced that it has purchased an initial order of GMP grade psilocybin from Psygen Labs Inc.
PharmaTher Announces Research Collaboration for Microneedle Delivery of Psychedelic Pharmaceuticals Feb 23 • 4 min read PharmaTher Inc. announced that they have entered into a sponsored research agreement with the Terasaki Institute to develop a novel microneedle patch that aims to deliver psychedelic pharmaceuticals.
Awakn Announces Results of the World’s First ‘MDMA in Alcohol Use Disorder’ Trial Feb 22 • 3 min read Awakn Life Sciences Inc. announced the publication of results from its CMO Dr. Ben Sessa’s Bristol Imperial MDMA in Alcoholism (BIMA) trial.